Cargando…

Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer

Liquid biopsy, which generally refers to the analysis of biological components such as circulating nuclear acids and circulating tumor cells in body fluids, particularly in peripheral blood, has shown good capacity to overcome several limitations faced by conventional tissue biopsies. Emerging evide...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Wei, Chen, Yigui, Yang, Jianwei, Zhuo, Changhua, Huang, Sha, Zhang, Hui, Shi, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876389/
https://www.ncbi.nlm.nih.gov/pubmed/33584829
http://dx.doi.org/10.3389/fgene.2021.634642
_version_ 1783649961572827136
author Gao, Wei
Chen, Yigui
Yang, Jianwei
Zhuo, Changhua
Huang, Sha
Zhang, Hui
Shi, Yi
author_facet Gao, Wei
Chen, Yigui
Yang, Jianwei
Zhuo, Changhua
Huang, Sha
Zhang, Hui
Shi, Yi
author_sort Gao, Wei
collection PubMed
description Liquid biopsy, which generally refers to the analysis of biological components such as circulating nuclear acids and circulating tumor cells in body fluids, particularly in peripheral blood, has shown good capacity to overcome several limitations faced by conventional tissue biopsies. Emerging evidence in recent decades has confirmed the promising role of liquid biopsy in the clinical management of various cancers, including colorectal cancer, which is one of the most prevalent cancers and the second leading cause of cancer-related deaths worldwide. Despite the challenges and poor clinical outcomes, patients with metastatic colorectal cancer can expect potential clinical benefits with liquid biopsy. Therefore, in this review, we focus on the clinical prospects of liquid biopsy in metastatic colorectal cancer, specifically with regard to the recently discovered various biomarkers identified on liquid biopsy. These biomarkers have been shown to be potentially useful in multiple aspects of metastatic colorectal cancer, such as auxiliary diagnosis of metastasis, prognosis prediction, and monitoring of therapy response.
format Online
Article
Text
id pubmed-7876389
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78763892021-02-12 Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer Gao, Wei Chen, Yigui Yang, Jianwei Zhuo, Changhua Huang, Sha Zhang, Hui Shi, Yi Front Genet Genetics Liquid biopsy, which generally refers to the analysis of biological components such as circulating nuclear acids and circulating tumor cells in body fluids, particularly in peripheral blood, has shown good capacity to overcome several limitations faced by conventional tissue biopsies. Emerging evidence in recent decades has confirmed the promising role of liquid biopsy in the clinical management of various cancers, including colorectal cancer, which is one of the most prevalent cancers and the second leading cause of cancer-related deaths worldwide. Despite the challenges and poor clinical outcomes, patients with metastatic colorectal cancer can expect potential clinical benefits with liquid biopsy. Therefore, in this review, we focus on the clinical prospects of liquid biopsy in metastatic colorectal cancer, specifically with regard to the recently discovered various biomarkers identified on liquid biopsy. These biomarkers have been shown to be potentially useful in multiple aspects of metastatic colorectal cancer, such as auxiliary diagnosis of metastasis, prognosis prediction, and monitoring of therapy response. Frontiers Media S.A. 2021-01-28 /pmc/articles/PMC7876389/ /pubmed/33584829 http://dx.doi.org/10.3389/fgene.2021.634642 Text en Copyright © 2021 Gao, Chen, Yang, Zhuo, Huang, Zhang and Shi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Gao, Wei
Chen, Yigui
Yang, Jianwei
Zhuo, Changhua
Huang, Sha
Zhang, Hui
Shi, Yi
Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer
title Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer
title_full Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer
title_fullStr Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer
title_full_unstemmed Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer
title_short Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer
title_sort clinical perspectives on liquid biopsy in metastatic colorectal cancer
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876389/
https://www.ncbi.nlm.nih.gov/pubmed/33584829
http://dx.doi.org/10.3389/fgene.2021.634642
work_keys_str_mv AT gaowei clinicalperspectivesonliquidbiopsyinmetastaticcolorectalcancer
AT chenyigui clinicalperspectivesonliquidbiopsyinmetastaticcolorectalcancer
AT yangjianwei clinicalperspectivesonliquidbiopsyinmetastaticcolorectalcancer
AT zhuochanghua clinicalperspectivesonliquidbiopsyinmetastaticcolorectalcancer
AT huangsha clinicalperspectivesonliquidbiopsyinmetastaticcolorectalcancer
AT zhanghui clinicalperspectivesonliquidbiopsyinmetastaticcolorectalcancer
AT shiyi clinicalperspectivesonliquidbiopsyinmetastaticcolorectalcancer